Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
40.76 USD | +0.04% | -9.00% | +166.25% |
05-10 | Wedbush Adjusts Vera Therapeutics' PT to $32 From $34, Keeps Neutral Rating | MT |
05-09 | Vera Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |